MX2024010608A - Derivados heterociclicos medio o macrociclicos sustituidos con bencilo y usos relacionados. - Google Patents
Derivados heterociclicos medio o macrociclicos sustituidos con bencilo y usos relacionados.Info
- Publication number
- MX2024010608A MX2024010608A MX2024010608A MX2024010608A MX2024010608A MX 2024010608 A MX2024010608 A MX 2024010608A MX 2024010608 A MX2024010608 A MX 2024010608A MX 2024010608 A MX2024010608 A MX 2024010608A MX 2024010608 A MX2024010608 A MX 2024010608A
- Authority
- MX
- Mexico
- Prior art keywords
- disorder
- macro
- medium
- substituted heterocycle
- related uses
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263315438P | 2022-03-01 | 2022-03-01 | |
| US202363439477P | 2023-01-17 | 2023-01-17 | |
| PCT/US2023/014275 WO2023167925A1 (en) | 2022-03-01 | 2023-03-01 | Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and related uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024010608A true MX2024010608A (es) | 2024-09-23 |
Family
ID=85772026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024010608A MX2024010608A (es) | 2022-03-01 | 2023-03-01 | Derivados heterociclicos medio o macrociclicos sustituidos con bencilo y usos relacionados. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20250236629A1 (https=) |
| EP (1) | EP4486748A1 (https=) |
| JP (1) | JP2025507852A (https=) |
| KR (1) | KR20240157067A (https=) |
| CN (1) | CN119110802A (https=) |
| AU (1) | AU2023228830A1 (https=) |
| CA (1) | CA3245204A1 (https=) |
| CL (1) | CL2024002576A1 (https=) |
| IL (1) | IL315237A (https=) |
| MX (1) | MX2024010608A (https=) |
| TW (1) | TW202400606A (https=) |
| WO (1) | WO2023167925A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12503475B2 (en) | 2020-09-03 | 2025-12-23 | Centessa Pharmaceuticals (Uk) Limited | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists |
| KR20250155550A (ko) | 2023-03-16 | 2025-10-30 | 다케다 야쿠힌 고교 가부시키가이샤 | 매크로시클릭 헤테로시클 화합물 및 이의 용도 |
| US20240425521A1 (en) | 2023-06-01 | 2024-12-26 | H. Lundbeck A/S | Spiromacrocyclic orexin 2 receptor agonists |
| WO2025124698A1 (en) | 2023-12-12 | 2025-06-19 | Idorsia Pharmaceuticals Ltd | Aryl sulfone and sulfanone derivatives as orexin receptor modulators |
| TW202542165A (zh) | 2023-12-19 | 2025-11-01 | 瑞士商愛杜西亞製藥有限公司 | 大環食慾素激動劑 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| US20200207734A1 (en) | 2017-08-03 | 2020-07-02 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
| SG11202106791XA (en) | 2019-01-31 | 2021-07-29 | Takeda Pharmaceuticals Co | Heterocyclic compound and use thereof |
| FI4065585T3 (fi) * | 2019-11-25 | 2025-09-26 | Alkermes Inc | Substituoituja makrosyklisiä yhdisteitä ja niihin liittyviä hoitomenetelmiä |
| WO2022051583A1 (en) * | 2020-09-03 | 2022-03-10 | Orexia Therapeutics Limited | Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and their uses as orexin-2 receptor agonists |
-
2023
- 2023-03-01 KR KR1020247032615A patent/KR20240157067A/ko active Pending
- 2023-03-01 IL IL315237A patent/IL315237A/en unknown
- 2023-03-01 WO PCT/US2023/014275 patent/WO2023167925A1/en not_active Ceased
- 2023-03-01 EP EP23713207.1A patent/EP4486748A1/en active Pending
- 2023-03-01 CN CN202380037293.8A patent/CN119110802A/zh active Pending
- 2023-03-01 TW TW112107384A patent/TW202400606A/zh unknown
- 2023-03-01 JP JP2024551975A patent/JP2025507852A/ja active Pending
- 2023-03-01 MX MX2024010608A patent/MX2024010608A/es unknown
- 2023-03-01 CA CA3245204A patent/CA3245204A1/en active Pending
- 2023-03-01 AU AU2023228830A patent/AU2023228830A1/en active Pending
-
2024
- 2024-08-28 US US18/817,943 patent/US20250236629A1/en active Pending
- 2024-08-29 CL CL2024002576A patent/CL2024002576A1/es unknown
-
2025
- 2025-04-11 US US19/177,396 patent/US20250289828A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN119110802A (zh) | 2024-12-10 |
| US20250289828A1 (en) | 2025-09-18 |
| CL2024002576A1 (es) | 2025-01-10 |
| TW202400606A (zh) | 2024-01-01 |
| US20250236629A1 (en) | 2025-07-24 |
| JP2025507852A (ja) | 2025-03-21 |
| IL315237A (en) | 2024-10-01 |
| EP4486748A1 (en) | 2025-01-08 |
| WO2023167925A1 (en) | 2023-09-07 |
| CA3245204A1 (en) | 2023-09-07 |
| AU2023228830A1 (en) | 2024-09-12 |
| KR20240157067A (ko) | 2024-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2022051596A8 (en) | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists | |
| MX2024010608A (es) | Derivados heterociclicos medio o macrociclicos sustituidos con bencilo y usos relacionados. | |
| EP3610874A1 (en) | Pharmaceutical composition containing mor agonist and kor agonist, and uses thereof | |
| BRPI0417687A (pt) | derivados de benzenossulfonilamino-piridin-2-ila e compostos relacionados como inibidores de 11-beta-hidroxiesteróide desidrogenase tipo 1 (11-beta-hsd-1) para o tratamento de diabetes e obesidade | |
| WO2012045883A1 (en) | Cyclopropylamine inhibitors of oxidases | |
| TW200606129A (en) | Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same | |
| NO20051265L (no) | Anvendelse av og noen nye imidazopyridiner | |
| KR20170108887A (ko) | NamPT 억제용 신규 화합물 및 이를 포함하는 조성물 | |
| BR112020010429A2 (pt) | uso de agonista de kor em combinação com agonista de mor na preparação de fármaco para tratamento da dor | |
| BR112019016248A2 (pt) | piridinas substituídas com hidrocarbilssulfonila e uso das mesmas no tratamento de câncer | |
| BR112019016233A2 (pt) | piridinas substituídas com heterociclilsulfonila e uso das mesmas no tratamento de câncer | |
| MX2023006578A (es) | Heteroaril-acetilenos, sus composiciones farmacéuticas y sus aplicaciones terapéuticas. | |
| JP7600131B2 (ja) | 神経系疾患の予防または治療用薬学的組成物 | |
| AU2011232341A1 (en) | Improved stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone | |
| CZ285633B6 (cs) | Použití indolových derivátů pro výrobu léčiv a farmaceutický prostředek | |
| EP3836912B1 (en) | Combinations of substituted benzamides and 5-asa agents | |
| NZ517485A (en) | Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia | |
| EP2668159A1 (en) | 4-tolyl-ethynyl-octahydro-indole-1-ester derivatives | |
| NO20082656L (no) | N-sulfamoyl-N'-benzopyranpiperidiner som inhibitorer av karbonsyreanhydraser | |
| EP4061371B1 (en) | Masitinib for the treatment of sickle cell disease | |
| KR102954666B1 (ko) | 병리학적 염증에 대한 새로운 의학적 치료 | |
| CN114874202B (zh) | 一种用于治疗阿尔茨海默症的药物及其用途 | |
| MX2024013549A (es) | Heterociclos novedosos, métodos de preparación y usos de los mismos | |
| BR112022008265A2 (pt) | Composições farmacêuticas contendo diácido de oligossacarídeo de alginato | |
| WO2025178571A1 (en) | Anti-non-tuberculous mycobacteria inhibitors |